Skip to content

International prospective registry on local treatment approaches in myxoid liposarcomas

Last updated: February 12, 2020

To prospectively study commonly used local treatment approaches in Myxoid Liposarcoma (MLS)

Dutch title

Internationale prospectieve registratie voor lokale behandelingen in myxoid liposarcomen

Acronym

Doremy Registry

Reference code

NCT04699292

Intervention model

Observational cohort study

Full description

In order to confirm the promising results of the 36 Gy dose level in the DOREMY trial (NCT02106312) and to compare outcome with other local treatment approaches

Inclusion criteria

  1. Age > 18 years
  2. By biopsy proven myxoid liposarcoma
  3. Performance score ECOG 0-2
  4. Written informed consent to share coded information in this international Registry

Exclusion criteria

  1. Prior radiotherapy to target area
  2. Pregnancy

Locations Netherlands

  • The Netherlands Cancer Institute
  • Academisch Medisch Centrum
  • Universitair Medisch Centrum Groningen
  • Leids Universitair Medisch Centrum
  • Maastro Clinic
  • Radboudumc

Contact

Name: dr. R.L.M. Haas
E-mail: r.haas@nki.nl
Phone: +31 (0)205129111
Address: NKI-AVL, Plesmanlaan 121, 1066 CX Amsterdam

Downloads:

Download Link Size Format
C1 Doremy Protocol 221 Kb pdf